Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Capital Employed: 2017-2025

Historic Return on Capital Employed for cbdMD (YCBD) over the last 8 years, with Sep 2025 value amounting to -0.31%.

  • cbdMD's Return on Capital Employed rose 61.00% to -0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.31%, marking a year-over-year increase of 61.00%. This contributed to the annual value of -0.30% for FY2025, which is 40.00% up from last year.
  • Per cbdMD's latest filing, its Return on Capital Employed stood at -0.31% for Q3 2025, which was down 18.33% from -0.26% recorded in Q2 2025.
  • cbdMD's Return on Capital Employed's 5-year high stood at -0.10% during Q1 2021, with a 5-year trough of -2.87% in Q2 2024.
  • In the last 3 years, cbdMD's Return on Capital Employed had a median value of -1.13% in 2023 and averaged -1.34%.
  • Per our database at Business Quant, cbdMD's Return on Capital Employed slumped by 210bps in 2024 and then spiked by 261bps in 2025.
  • Quarterly analysis of 5 years shows cbdMD's Return on Capital Employed stood at -0.41% in 2021, then tumbled by 134bps to -1.75% in 2022, then declined by 27bps to -2.02% in 2023, then skyrocketed by 78bps to -1.23% in 2024, then skyrocketed by 61bps to -0.31% in 2025.
  • Its Return on Capital Employed was -0.31% in Q3 2025, compared to -0.26% in Q2 2025 and -0.93% in Q1 2025.